Bicillin L-A shortage continues, with CDC prioritizing pregnancy treatment

The Bicillin L-A shortage is still ongoing in April 2026, and the CDC says limited supplies should be preserved for pregnant patients whenever possible. That matters because benzathine penicillin G is the only recommended treatment for syphilis during pregnancy and for preventing congenital syphilis.

For other patients, the practical issue is access: some pharmacies and clinics may not be able to fill a prescription right away, while temporary options may be available in some settings but not all.

What Bicillin L-A is

Bicillin L-A is a brand name for benzathine penicillin G, an injectable antibiotic used to treat syphilis. The CDC says it is the only FDA-approved formulation of benzathine penicillin G in the United States. That makes a supply problem more difficult, because there is not a direct U.S.-approved substitute in the same form.

Why the CDC is prioritizing pregnancy

In its April 2026 update, the CDC said jurisdictions should strongly consider preserving benzathine penicillin G for patients who are pregnant. The agency says this is because penicillin is the only recommended treatment for pregnant patients and babies with congenital syphilis.

That public-health focus is tied to preventing infections that can be passed from parent to baby during pregnancy. The CDC’s guidance is aimed at helping health departments and clinicians use the limited supply where it is most critical.

What the FDA has done

The FDA tracks drug shortages at the national level and works with manufacturers to try to reduce the impact of supply disruptions. The agency says shortages often stem from manufacturing or quality problems, production delays, raw-material issues, or sudden increases in demand.

For Bicillin L-A, the FDA has also allowed temporary importation of Lentocilin, another benzathine penicillin product, to help address the shortage. The CDC says information for health care providers is available on how Lentocilin should be used, but availability can vary by location and setting.

What patients should do if a pharmacy cannot fill it

If a pharmacy cannot fill a prescription for Bicillin L-A, patients should contact the prescribing clinician or pharmacist promptly about next steps. The FDA says if a drug is already listed in its shortage database, clinicians and pharmacists should discuss other treatment options during the shortage.

Patients should not assume a local stock problem means the medicine is gone everywhere. The FDA says some shortages are temporary or localized, but local access problems can still be a sign of broader supply strain.

What remains uncertain

Two things remain unclear for everyday readers: how quickly local access will improve and whether temporary alternatives are available everywhere they are needed. The CDC and FDA have both said the shortage is being managed, but access may still vary by location and clinical setting.

People who are pregnant, or who may need syphilis treatment during pregnancy, may be most affected if supply is tight. For others, the main issue is whether a clinic or pharmacy can obtain the correct product in time.

What readers can do

Ask the prescribing clinician or pharmacist whether the pharmacy has the drug in stock or can order it.
If the prescription cannot be filled, ask how quickly another site may have it available.
If you are pregnant and being treated for syphilis, contact your clinician promptly if access is delayed.
Do not change or stop any prescribed treatment without talking with a qualified clinician first.

For readers, the key takeaway is simple: the shortage is still active, pregnancy treatment is being protected as a priority, and local access may still be uneven while the supply situation improves.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.